---
figid: PMC4259928__WJCO-5-1020-g001
figlink: /pmc/articles/PMC4259928/figure/F1/
number: Figure 1
caption: 'Intracellular estrogen receptor and epidermal growth factor receptor signaling
  pathway in non-small cell lung cancer. A: Mechanisms of ER and EGFR signaling in
  NSCLC. E2 (17β-estradiol)-bound ER acts in part as a transcription factor in the
  nucleus. Once the ER binds to the DNA in the estrogen response element of a gene,
  it generally recruits co-activator complexes to modulate gene transcription (genomic
  signal). In addition, E2-bound ER also acts in the cytoplasm (non-genomic signal)
  by interacting with downstream mediators of EGFR signaling, such as MAPK and PI3K/AKT.
  EGFR is a cell membrane receptor tyrosine kinase that transmits a signal when it
  binds EGF; B: Mechanisms of combination therapy for NSCLC. The estrogen antagonist
  fulv binds to ERs and blocks estrogen signaling. EGFR-TKIs, such as gefitinib or
  erlotinib, bind to mtEGFR and inhibit EGFR signaling. Both treatments block the
  interaction between ER and EGFR signaling. EGFR: Epidermal growth factor receptor;
  ER: Estrogen receptor; TKI: Tyrosine kinase inhibitor.'
pmcid: PMC4259928
papertitle: Estrogen receptors as the novel therapeutic biomarker in non-small cell
  lung cancer.
reftext: Hideki Kawai. World J Clin Oncol. 2014 Dec 10;5(5):1020-1027.
pmc_ranked_result_index: '10281'
pathway_score: 0.9165171
filename: WJCO-5-1020-g001.jpg
figtitle: Intracellular estrogen receptor and epidermal growth factor receptor signaling
  pathway in non-small cell lung cancer
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4259928__WJCO-5-1020-g001.html
  '@type': Dataset
  description: 'Intracellular estrogen receptor and epidermal growth factor receptor
    signaling pathway in non-small cell lung cancer. A: Mechanisms of ER and EGFR
    signaling in NSCLC. E2 (17β-estradiol)-bound ER acts in part as a transcription
    factor in the nucleus. Once the ER binds to the DNA in the estrogen response element
    of a gene, it generally recruits co-activator complexes to modulate gene transcription
    (genomic signal). In addition, E2-bound ER also acts in the cytoplasm (non-genomic
    signal) by interacting with downstream mediators of EGFR signaling, such as MAPK
    and PI3K/AKT. EGFR is a cell membrane receptor tyrosine kinase that transmits
    a signal when it binds EGF; B: Mechanisms of combination therapy for NSCLC. The
    estrogen antagonist fulv binds to ERs and blocks estrogen signaling. EGFR-TKIs,
    such as gefitinib or erlotinib, bind to mtEGFR and inhibit EGFR signaling. Both
    treatments block the interaction between ER and EGFR signaling. EGFR: Epidermal
    growth factor receptor; ER: Estrogen receptor; TKI: Tyrosine kinase inhibitor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - PIK3R6
  - PIK3R5
  - AKT3
  - AKT2
  - MAPK10
  - MAPK12
  - MAPK1
  - PIK3R4
  - EGF
  - MAPK9
  - PIK3R3
  - PIK3CG
  - PIK3CA
  - MAPK13
  - MAPK11
  - MAPK14
  - PIK3CB
  - PIK3CD
  - MAPK8
  - MAPK3
genes:
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals: []
diseases: []
---
